Antithrombotic Treatment in Elderly Patients with Atrial Fibrillation

被引：10
|
作者：
Suarez Fernandez, C. [1 ]
Camafort, M. [2 ]
Cepeda Rodrigo, J. M. [3 ]
Diez-Manglano, J. [4 ]
Formiga, F. [5 ]
Reino, A. Pose [6 ]
Tiberio, G. [7 ]
Mostaza, J. M.
机构：
[1] Hosp Univ La Princesa, Grp Riesgo Vasc, SEMI, Madrid, Spain
[2] Hosp Clin Barcelona, Grp Riesgo Vasc, SEMI, Barcelona, Spain
[3] Hosp Vega Baja Orihuela, Grp Riesgo Vasc, SEMI, Alicante, Spain
[4] Hosp Royo Villanova, Grp Riesgo Vasc, SEMI, Zaragoza, Spain
[5] Hosp Univ Bellvitge, Grp Riesgo Vasc, SEMI, Barcelona, Spain
[6] Complexo Hosp Univ Santiago, Grp Riesgo Vasc, SEMI, Santiago De Compostela, Spain
[7] Hosp Virgen del Camino, Grp Riesgo Vasc, SEMI, Pamplona, Spain
[8] Hosp Carlos III, Grp Riesgo Vasc, SEMI, Madrid, Spain
来源：
REVISTA CLINICA ESPANOLA | 2015年 / 215卷 / 03期
关键词：
Elderly; Nonvalvular atrial fibrillation; Guidelines; Vitamin K antagonists; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; STROKE PREVENTION; ORAL ANTICOAGULATION; WARFARIN THERAPY; RISK-FACTORS; PREVALENCE; ADULTS; RECOMMENDATIONS; METAANALYSIS; POPULATION; GUIDELINES;
D O I：
10.1016/j.rce.2014.11.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Atrial fibrillation (AF) in the elderly is a complex condition due to the high number of frequently associated comorbidities, such as cardiovascular and kidney disease, cognitive disorders, falls and polypharmacy. Except when contraindicated, anticoagulation is necessary for preventing thromboembolic events in this population. Both vitamin K antagonists and direct oral anticoagulants (dabigatran, rivaroxaban and apixaban) are indicated in this context. Renal function should be closely monitored for this age group when these drugs are used. In recent years, various clinical practice guidelines have been published on patients with AF. The majority of these guidelines make specific recommendations on the clinical characteristics and treatment of elderly patients. In this update, we review the specific comments on the recommendations concerning antithrombotic treatment in elderly patients with nonvalvular AF. (C) 2014 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码：171 / 181
页数：11
相关论文
共 50 条
  • [41] Clinical Analysis of Antithrombotic Treatment and Occurrence of Stroke in Elderly Patients with Non-valvular Persistent Atrial Fibrillation
    Chen, S.
    Zhang, Z. X.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S493 - S493
  • [42] Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation
    Camm, A. John
    Accetta, Gabriele
    Ambrosio, Giuseppe
    Atar, Dan
    Bassand, Jean-Pierre
    Berge, Eivind
    Cools, Frank
    Fitzmaurice, David A.
    Goldhaber, Samuel Z.
    Goto, Shinya
    Haas, Sylvia
    Kayani, Gloria
    Koretsune, Yukihiro
    Mantovani, Lorenzo G.
    Misselwitz, Frank
    Oh, Seil
    Turpie, Alexander G. G.
    Verheugt, Freek W. A.
    Kakkar, Ajay K.
    Lucas Luciardi, Hector
    Gibbs, Harry
    Brodmann, Marianne
    Cools, Frank
    Pereira Barretto, Antonio Carlos
    Connolly, Stuart J.
    Spyropoulos, Alex
    Eikelboom, John
    Corbalan, Ramon
    Hu, Dayi
    Jansky, Petr
    Nielsen, Jorn Dalsgaard
    Ragy, Hany
    Raatikainen, Pekka
    Le Heuzey, Jean-Yves
    Darius, Harald
    Keltai, Matyas
    Kakkar, Sanjay
    Sawhney, Jitendra Pal Singh
    Agnelli, Giancarlo
    Koretsune, Yukihiro
    Sanchez Diaz, Carlos Jerjes
    Ten Cate, Hugo
    Atar, Dan
    Stepinska, Janina
    Panchenko, Elizaveta
    Lim, Toon Wei
    Jacobson, Barry
    Oh, Seil
    Vinolas, Xavier
    Rosenqvist, Marten
    [J]. HEART, 2017, 103 (04) : 307 - 314
  • [43] Antithrombotic Treatment after Carotid Stenting in Patients with Concomitant Atrial Fibrillation
    Pardo-Galiana, B.
    Medina-Rodriguez, M.
    Millan-Vazquez, M.
    Cabezas-Rodriguez, J. A.
    Lebrato-Hernandez, L.
    Ainz-Gomez, L.
    Zapata-Arriaza, E.
    Ortega, J.
    De Alboniga-Chindurza, A.
    Montaner, J.
    Gonzalez, A.
    Moniche, F.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2022, 43 (05) : 727 - 730
  • [44] Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation A real-world experience
    Gorczyca, Iwona
    Jelonek, Olga
    Michalska, Anna
    Chrapek, Magdalena
    Walek, Pawel
    Wozakowska-Kaplon, Beata
    [J]. MEDICINE, 2020, 99 (29) : E21209
  • [45] Evaluation of antithrombotic treatment in institutionalized geriatric patients with nonvalvular atrial fibrillation
    Alaba-Trueba, Javier
    Arriola-Manchola, Enrique
    Ferro-Uriguen, Alexander
    Beobide-Telleria, Idoia
    Martinez-Arrechea, Silvia
    [J]. FARMACIA HOSPITALARIA, 2021, 45 (04) : 170 - 175
  • [46] Antithrombotic treatment for incident atrial fibrillation in patients with permanent pacemakers, is it necessary?
    Sandgren, E.
    Rorsman, C.
    Engdahl, J.
    Edvardsson, N.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 771 - 771
  • [47] ATRIAL-FIBRILLATION, STROKE, AND ANTITHROMBOTIC TREATMENT
    CHENG, TO
    [J]. AMERICAN HEART JOURNAL, 1994, 127 (04) : 961 - 968
  • [48] Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
    Huisman, M. V.
    [J]. NETHERLANDS HEART JOURNAL, 2021, 29 (03) : 119 - 120
  • [49] Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation
    Pennlert, Johanna
    Asplund, Kjell
    Carlberg, Bo
    Wiklund, Per-Gunnar
    Wisten, Aase
    Asberg, Signild
    Eriksson, Marie
    [J]. STROKE, 2015, 46 (08) : 2094 - 2099
  • [50] Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment
    Eshmatov, O. R.
    Khlynin, M. S.
    Batalov, R. E.
    Archakov, E. A.
    Kisteneva, I. V.
    [J]. RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (02) : 160 - 166
12345